Clinical Trial Detail

NCT ID NCT03563157
Title QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors NantKwest, Inc.
Indications

colorectal cancer

Therapies

Aldoxorubicin + ALT-803 + Avelumab + Capecitabine + Cetuximab + Cyclophosphamide + ETBX-011 + ETBX-021 + ETBX-051 + ETBX-061 + Fluorouracil + GI-4000 + GI-6207 + GI-6301 + haNK cells + Leucovorin + Nab-paclitaxel + Oxaliplatin + Regorafenib + Trastuzumab

Regorafenib

Age Groups: adult senior

Additional content available in CKB BOOST